Kimi Iguchi
Director of Finance/CFO chez SAGE THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Actuellement, Kimi E. Iguchi occupe le poste de directrice financière et trésorière de SAGE Therapeutics, Inc. Mme Iguchi est également membre du conseil d'administration de Disarm Therapeutics, Inc. Auparavant, elle a été vice-présidente des finances de Cyberkinetics Neurotechnology Systems, Inc. et directrice de l'exploitation pour la région de l'Amérique du Nord de Santhera Pharmaceuticals Holding AG, directrice principale des rapports externes de Biogen, Inc. et directrice des finances de Biogen MA, Inc. (une filiale de Biogen, Inc.), directrice principale des finances, des rapports et de l'analyse chez Millennium Pharmaceuticals, Inc. et directrice de l'assurance commerciale chez PricewaterhouseCoopers LLP. Mme Iguchi a obtenu un diplôme de premier cycle à l'université Drew et un MBA à l'université Northeastern.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0,14% | 13/02/2024 | 81 679 ( 0,14% ) | 2 M $ | 31/03/2024 |
Postes actifs de Kimi Iguchi
| Sociétés | Poste | Début |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2013 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Director/Board Member | 25/10/2018 |
Anciens postes connus de Kimi Iguchi
| Sociétés | Poste | Fin |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01/09/2011 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Director of Finance/CFO | 31/05/2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/1998 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/1995 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Formation de Kimi Iguchi
| Drew University | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
